跳至主要内容
临床试验/CTRI/2025/02/080959
CTRI/2025/02/080959尚未招募Phase 3 4

A diagnostic and Ayurvedic therapeutic approach for endometrial receptivity in patients of polycystic ovarian syndrome based on Radiological Uterine biophysical profile, Immunohistochemistry and Gene expression.

Institute of EminenceIOE2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2025年3月2日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
10
试验地点
2
主要终点
diagnostic alteration in endometrial receptivity

研究概览

简要总结

Gap in knowledge :As many previous published researches showed that uttarabasti

has role in improving the chances of conception and enhanced fertility but no work

has been done to show effect of uttarabasti on markers of endometrial receptivity in

specific.

Novelty :The present study framed mainly for disorders of endometrial receptivity in

patients with PCOS, where we planned to see the differences in the indicators of

endometrial receptivity including Applebaum’s score via sonography, alphavbeta3integrin via immunihistochemical study and 7 genes expression (related to

endometrial receptivity as per previous published research work) between PCOS

diagnosed female patients with fertile females having live births as control group

Objectives :Assessment of Applebaum’s score, AlphaVBeta3 integrin expression

and expression of 7 genes related to endometrial receptivity (HOXA10, HOXA11,

LIF, AR, Mucin1, PGR, alphavbeta3) during implantation window in patients of

PCOS.

Methods :Itwill be an open label controlled clinical trial and the setting site will be

the BHU,Varanasi.

Expected outcome :Uttarabasti can improve endometrial receptivity by increasing,

Applebaum’s score, alphavbeta3 integrin expression and by up regulating gene

expression during implantation window in patients of PCOS.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
21.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • Diagnosed cases of PCOS yearning conception.
  • Patient giving consent for uttarabasti procedure and investigations And willing for follow ups.

排除标准

  • <21 years and >40 years of age patient.
  • Unmarried PCOS patients Patients with huge myoma and adenomyosis.
  • Extensive cervical erosion and vaginal infection.
  • HIV, HBsAg, HCV positive Patients.

结局指标

主要结局

diagnostic alteration in endometrial receptivity

时间窗: baseline, after 12 weeks

次要结局

  • endometrial receptivity improvements(baseline, after 4weeks, after 8 weeks)

研究者

发起方
Institute of EminenceIOE
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Anuradha Roy

Banaras Hindu University, Varanasi

研究点 (2)

Loading locations...

相似试验